期刊文献+

视黄醇结合蛋白4与新诊断2型糖尿病合并非酒精性脂肪肝的关系研究 被引量:8

The correlation between retinol binding protein 4 and nonalcoholic fatty liver disease in newly-diagnosed type 2 diabetes mellitus
原文传递
导出
摘要 目的:探讨新诊断的2型糖尿病(type 2 diabetes mellitus,T2DM)合并非酒精性脂肪肝(nonalcoholic fatty liver disease,NAFLD)的代谢特征及与视黄醇结合蛋白4(retinol binding protein 4,RBP4)的关系。方法:收集新诊断的T2DM住院患者216例,根据是否合并NAFLD分为T2DM伴有NAFLD组144例和T2DM不伴NAFLD组72例。测量两组患者血压、体质指数(body mass index,BMI)、血脂[总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)、高密度脂蛋白胆固醇(high density lipoprotein cholesterol,HDL-C)、低密度脂蛋白胆固醇(low density lipoprotein cholestorol,LDL-C)、脂蛋白a(lipoprotein a,Lp-a)]、空腹血糖(fasting blood glucose,FBG)、空腹胰岛素(fasting insulin,FINS)、糖化血红蛋白(HbA1c)、血尿酸(uric acid,UA)、肝功能[γ-谷氨酰转肽酶(γ-glutamyl transpeptidase,γ-GGT)、丙氨酸转氨酶(alanine transarninase,ALT)、天门冬氨酸转氨酶(aspartate transarninase,AST)]及RBP4,比较上述指标在两组间有无差异,并对相关指标做Logistic回归或Pearson相关分析。结果:新诊断的T2DM伴有NAFLD患者的BMI、收缩压、舒张压均高于T2DM不伴NAFLD组,较正年龄、性别、BMI后,T2DM伴NAFLD患者的TG、TC、FINS、胰岛素抵抗指数、γ-GGT、ALT、UA、RBP4显著高于T2DM不伴NAFLD组(P<0.05)。2组FBG、HbA1c、HDL-C、LDL-C、Lp-a、AST在较正年龄、性别、BMI后差异无统计学意义(P>0.05)。Logistic回归分析发现RBP4、BMI、ALT是新诊断的T2DM合并NAFLD的独立危险因素。T2DM合并NAFLD组的RBP4与胰岛素抵抗指数、HbA1c、FINS、γ-GGT、UA显著相关(P<0.05)。结论:新诊断的T2DM伴有NAFLD较不伴NAFLD患者存在明显的胰岛素抵抗,并与代谢综合征组分(肥胖、高血压、高脂血症、高尿酸血症)相伴发生;RBP4及BMI、ALT在预测T2DM合并NAFLD风险方面有重要临床价值。 Objective:To investigate the metabolic characteristics of newly-diagnosed type 2 diabetes with nonalcoholic fatty liver disease (NAFLD) and the correlation between retinol binding protein 4 in newly-diagnosed type 2 diabetes with nonalcoholic fatty liver disease. Methods:A total of 216 patients with newly-diagnosed type 2 diabetes were enrolled in this study. They were divided into two groups according to with or without NAFLD. We compared the blood pressure,body mass index (BMI),blood lipids [TC ,TG, HDL, LDL, Lp (a)], fasting glucose, fasting insulin, HbAlc,uric acid, liver function and retinol binding protein 4 (RBP4). Logistic regression and Pearson correlation were performed to analyze the related factors. Results:The levels of BMI, systolic blood pressure, diastolic blood pressure were much higher in T2DM with NAFLD group than T2DM without NAFLD group. After adjustment of age, sex and BMI, the levels of triglyceride, total cholesterol, fasting insulin, insulin resistance index (HOMA-IR), ALT,',/-GGT, uric acid,RBP4 were significant higher in newly-diagnosed type 2 diabetes with NAFLD disease (P 〈 0.05). In logistic regression analysis,BMI,ALT and RBP4 were significant and independent predictors of newly-diagnosed type 2 diabetes with NAFLD (P 〈 0.05). RBP4 was significantly correlated with HOMA-IR, HbAlc, FINS,γ-GGT, UA (P 〈 0.05). Conclusion: The results suggest that newly-diagnosed type 2 diabetes with NAFLD displayed with the components of metabolic syndrome RBP4 may be an important indicator of nonalcoholic fatty liver disease in newly-diagnosed type 2 diabetes.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第5期646-650,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省中医局项目(LZ11080)
关键词 2型糖尿病 非酒精性脂肪肝 视黄醇结合蛋白4 type 2 diabetes mellitus nonalcoholic fatty liver disease retinol binding protein 4
  • 相关文献

参考文献20

  • 1Haukeland JW, Konopski Z,Linnestad P, et al. Abnor-mal glucose tolerance is a predictor of steatohepatitis andfibrosis in patients with non-alcoholic fatty liver disease[J]. Scand J Gastroenterol,2005,40( 12) : 1469—1477.
  • 2Musso G, Cassader M,De Michieli F, et al. Nonalco-holic steatohepatitis versus steatosis : adipose tissue in-sulin resistance and dysfunctional response to fat inges-tion predict liver injury and altered glucose and lipopro-tein metabolism[J]. Hepatology,2012,56(3) : 933-942.
  • 3Valenti L, Dongiovanni P, Pipemo A, et al. Alpha 1-an-titrypsin mutations in NAFLD: high prevalence and asso-ciation with altered iron metabolism but not with liverdamage [J]. Hepatology, 2006,44(4) : 857-864.
  • 4周佳雁,马向华,沈捷.肥胖青少年非酒精性脂肪肝脂代谢异常与胰岛素、瘦素的相关性[J].江苏医药,2011,37(3):315-317. 被引量:2
  • 5Lu H, Zeng L, Liang B, et al. High prevalence of coro-nary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease[J]. Arch Med Res,2009,40(7):571-575.
  • 6Bonapace S, Perseghin G,Molon G, et al. Nonalcoholicfatty liver disease is associated with left ventricular dias-tolic dysfunction in patients with type 2 diabetes [J]. Dia-betes Care,2012,35(2):389-395.
  • 7van HoekM,DehghanA, Zillikens MC,et al. An RBP4promoter polymorphism increases risk of type 2 diabetes[J]. Diabetologia,2008,51(8) :1423-1428.
  • 8Suh JB, Kim SM, Cho GJ, et al. Elevated serum retinol-binding protein 4 is associated with insulin resistance inolder women[]]. Metabolism,2010,59(1) : 118-122.
  • 9Ingelsson E, Sundstrom J, Melhus H, et al. Circulatingretinol-binding protein 4,cardiovascular risk factors andprevalent cardiovascular disease in elderly [J]. Atherosc-lerosis ,2009,206(1):239-244.
  • 10林爱萍,于健,祖颖,欧阳清,杨蓥境,苏珂,龙艳.2型糖尿病合并非酒精性脂肪肝患者动脉硬化危险因素的分析[J].中华老年心脑血管病杂志,2011,13(5):404-406. 被引量:17

二级参考文献70

  • 1赵维纲,朱惠娟.肥胖致胰岛素抵抗和高血糖的机制、治疗及评测[J].中国医学科学院学报,2010,32(1):7-12. 被引量:25
  • 2卢曙芳,沈建国,朱麒钱,官莉莉.2型糖尿病患者颈动脉内膜中层厚度与细胞间黏附分子1、C反应蛋白的相关性[J].中华内分泌代谢杂志,2006,22(4):358-359. 被引量:20
  • 3邹大进,吴鸿.腹型肥胖致胰岛素抵抗的机制及治疗展望[J].中国糖尿病杂志,2006,14(4):309-312. 被引量:39
  • 4Lighte K, Bourass I, Sels JP, et al. Non-alcoholic steatohepatitis: review of a growing medical problem. Eur J Interm Med, 2004, 15 : 10-21.
  • 5Pagano G,Pacini G, Musso G,et al. Non-alcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for anetiologic as sociation. Hepatology, 2002,35 : 367-372.
  • 6Schindhelm RK, Diamant M, Dekker JM, et al. Alanine amino transferase as a marker of non alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev, 2006,22 : 437-443.
  • 7Jia L, Long S, Fu M, et al. Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/ high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses [J].Metabolism: Clinical and Experimental, 2006,55 (9) : 1141-1148.
  • 8Walldius G, Jungner I. Apolipoprotein B and apolipoprotein A-Lrisk indicators of coronary heart disease and targets for lipid-modifying therapy[J].Journal Internal Medicine, 2004, 255(2): 188-205.
  • 9Agoston-Coldea L, Zdrenghea D,Pop D, et al. Apolipoproteins A-I and B markers in coronary risk evaluation[J]. Romanian Journal of Internal Medicine, 2007,45(3) :251-258.
  • 10Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon[J]? Diabetologia, 2008,51(11) : 1947-1953.

共引文献42

同被引文献109

引证文献8

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部